28464602|t|Attenuation of High Glucose - Induced Rat Cardiomyocyte Apoptosis by Exendin-4 via Intervention of HO-1 / Nrf-2 and the PI3K/AKT Signaling Pathway
28464602|a|Exendin-4, a glucagon-like peptide-1 receptor agonist, demonstrated cytoprotective actions beyond glycemic control in recent studies. The aims of the present study were to investigate the effects of exendin-4 on high glucose (HG)- induced cardiomyocyte apoptosis and the possible mechanisms. Rat cardiomyocytes were divided into 3 groups: normal glucose group (NG group), HG group and HG + exendin-4 group (HG + Ex Group). Cardiomyocyte apoptosis was evaluated by double-staining with annexin V-fluorescein isothiocyanate (FITC)/ propidium iodide (PI) and flow cytometry. Intracellular reactive oxygen species (ROS) production was detected by 2’,7’-dichlorodihydrofluorescein diacetate (DCHF-DA) incubation and fluorescence microscopy. LY294002 (LY), a phosphoinositide 3-kinase (PI3K) pathway inhibitor, was added to the medium of the HG + Ex + LY Group for further western blot analysis. The proteins analyzed involved oxidative stress - associated proteins, heme oxygenase-1 (HO-1) and nuclear factor E2-related factor 2 (Nrf-2), and apoptosis - associated proteins, caspase-3, Bax/B-cell lymphoma 2 (Bcl-2) and p-AKT / AKT. HG treatment induced cardiomyocyte apoptosis (P = 0.00) and clearly upregulated ROS production (P = 0.00); exendin-4 co-incubation also ameliorated cardiomyocyte apoptosis (P = 0.004) and decreased ROS (P = 0.00) level significantly. HO-1 and Nrf-2 protein expression levels decreased significantly in the HG group (P < 0.05), but the levels were elevated by exendin-4 intervention (P < 0.05). Furthermore, exendin-4 attenuated HG - induced higher protein expression, including cleaved caspase-3 and Bax, increased the expression of Bcl-2 protein (P < 0.05). However, these impacts of exendin-4 were counteracted significantly by co-incubation with LY294002. In addition, exendin-4 ameliorated HG - induced p-AKT / AKT lower expression, and this impact was also suppressed by LY294002. Exendin-4 ameliorates HG - induced cardiomyocyte apoptosis, and the mechanisms may involve anti-oxidative stress via the HO-1 / Nrf-2 system, as well as intervention of the PI3K/AKT signaling pathway.
28464602	15	27	High Glucose	T103	UMLS:C0017725
28464602	38	41	Rat	T204	UMLS:C0034693
28464602	42	55	Cardiomyocyte	T017	UMLS:C0225828
28464602	56	65	Apoptosis	T038	UMLS:C0162638
28464602	69	78	Exendin-4	T103	UMLS:C0167117
28464602	83	95	Intervention	T058	UMLS:C0184661
28464602	99	103	HO-1	T103	UMLS:C0538674
28464602	106	111	Nrf-2	T103	UMLS:C0289507
28464602	147	156	Exendin-4	T103	UMLS:C0167117
28464602	160	200	glucagon-like peptide-1 receptor agonist	T103	UMLS:C2917359
28464602	215	237	cytoprotective actions	T038	UMLS:C0524828
28464602	245	261	glycemic control	T033	UMLS:C0522082
28464602	305	310	study	T062	UMLS:C2603343
28464602	346	355	exendin-4	T103	UMLS:C0167117
28464602	359	371	high glucose	T103	UMLS:C0017725
28464602	373	375	HG	T103	UMLS:C0017725
28464602	386	399	cardiomyocyte	T017	UMLS:C0225828
28464602	400	409	apoptosis	T038	UMLS:C0162638
28464602	439	442	Rat	T204	UMLS:C0034693
28464602	443	457	cardiomyocytes	T017	UMLS:C0225828
28464602	486	500	normal glucose	T103	UMLS:C0017725
28464602	508	510	NG	T103	UMLS:C0017725
28464602	519	521	HG	T103	UMLS:C0017725
28464602	532	534	HG	T103	UMLS:C0017725
28464602	537	546	exendin-4	T103	UMLS:C0167117
28464602	554	556	HG	T103	UMLS:C0017725
28464602	559	561	Ex	T103	UMLS:C0167117
28464602	570	583	Cardiomyocyte	T017	UMLS:C0225828
28464602	584	593	apoptosis	T038	UMLS:C0162638
28464602	611	626	double-staining	T058	UMLS:C0022885
28464602	632	668	annexin V-fluorescein isothiocyanate	T103	UMLS:C0085216
28464602	670	674	FITC	T103	UMLS:C0085216
28464602	677	693	propidium iodide	T103	UMLS:C0033470
28464602	695	697	PI	T103	UMLS:C0033470
28464602	703	717	flow cytometry	T058	UMLS:C0016263
28464602	719	732	Intracellular	T082	UMLS:C0178719
28464602	778	786	detected	T033	UMLS:C0442726
28464602	790	832	2’,7’-dichlorodihydrofluorescein diacetate	T103	UMLS:C0670829
28464602	834	841	DCHF-DA	T103	UMLS:C0670829
28464602	843	853	incubation	T058	UMLS:C1439852
28464602	858	881	fluorescence microscopy	T058	UMLS:C0026022
28464602	883	891	LY294002	T103	UMLS:C0251991
28464602	893	895	LY	T103	UMLS:C0251991
28464602	900	925	phosphoinositide 3-kinase	T103	UMLS:C0044602
28464602	927	931	PI3K	T103	UMLS:C0044602
28464602	933	940	pathway	T038	UMLS:C1704259
28464602	969	975	medium	T103	UMLS:C0010454
28464602	983	985	HG	T103	UMLS:C0017725
28464602	988	990	Ex	T103	UMLS:C0167117
28464602	993	995	LY	T103	UMLS:C0251991
28464602	1014	1035	western blot analysis	T058	UMLS:C0949466
28464602	1041	1049	proteins	T103	UMLS:C0033684
28464602	1050	1058	analyzed	T062	UMLS:C0936012
28464602	1068	1084	oxidative stress	T038	UMLS:C0242606
28464602	1087	1106	associated proteins	T103	UMLS:C0033684
28464602	1108	1124	heme oxygenase-1	T103	UMLS:C0538674
28464602	1126	1130	HO-1	T103	UMLS:C0538674
28464602	1136	1170	nuclear factor E2-related factor 2	T103	UMLS:C0289507
28464602	1172	1177	Nrf-2	T103	UMLS:C0289507
28464602	1184	1193	apoptosis	T038	UMLS:C0162638
28464602	1196	1215	associated proteins	T103	UMLS:C0033684
28464602	1217	1226	caspase-3	T103	UMLS:C0291573
28464602	1228	1249	Bax/B-cell lymphoma 2	T103	UMLS:C0219474
28464602	1251	1256	Bcl-2	T103	UMLS:C0219474
28464602	1262	1267	p-AKT	T103	UMLS:C0164786
28464602	1270	1273	AKT	T103	UMLS:C0164786
28464602	1275	1277	HG	T103	UMLS:C0017725
28464602	1296	1309	cardiomyocyte	T017	UMLS:C0225828
28464602	1310	1319	apoptosis	T038	UMLS:C0162638
28464602	1343	1354	upregulated	T038	UMLS:C0041904
28464602	1355	1358	ROS	T103	UMLS:C0162772
28464602	1382	1391	exendin-4	T103	UMLS:C0167117
28464602	1392	1405	co-incubation	T058	UMLS:C1439852
28464602	1423	1436	cardiomyocyte	T017	UMLS:C0225828
28464602	1437	1446	apoptosis	T038	UMLS:C0162638
28464602	1473	1476	ROS	T103	UMLS:C0162772
28464602	1509	1513	HO-1	T103	UMLS:C0538674
28464602	1518	1523	Nrf-2	T103	UMLS:C0289507
28464602	1524	1542	protein expression	T038	UMLS:C1171362
28464602	1581	1583	HG	T103	UMLS:C0017725
28464602	1634	1643	exendin-4	T103	UMLS:C0167117
28464602	1644	1656	intervention	T058	UMLS:C0184661
28464602	1682	1691	exendin-4	T103	UMLS:C0167117
28464602	1703	1705	HG	T103	UMLS:C0017725
28464602	1723	1741	protein expression	T038	UMLS:C1171362
28464602	1761	1770	caspase-3	T103	UMLS:C0291573
28464602	1775	1778	Bax	T103	UMLS:C0219474
28464602	1794	1804	expression	T038	UMLS:C1171362
28464602	1808	1821	Bcl-2 protein	T103	UMLS:C4042483
28464602	1860	1869	exendin-4	T103	UMLS:C0167117
28464602	1905	1918	co-incubation	T058	UMLS:C1439852
28464602	1924	1932	LY294002	T103	UMLS:C0251991
28464602	1947	1956	exendin-4	T103	UMLS:C0167117
28464602	1969	1971	HG	T103	UMLS:C0017725
28464602	1982	1987	p-AKT	T103	UMLS:C0164786
28464602	1990	1993	AKT	T103	UMLS:C0164786
28464602	1994	2010	lower expression	T038	UMLS:C1171362
28464602	2051	2059	LY294002	T103	UMLS:C0251991
28464602	2061	2070	Exendin-4	T103	UMLS:C0167117
28464602	2083	2085	HG	T103	UMLS:C0017725
28464602	2096	2109	cardiomyocyte	T017	UMLS:C0225828
28464602	2110	2119	apoptosis	T038	UMLS:C0162638
28464602	2152	2173	anti-oxidative stress	T038	UMLS:C1148560
28464602	2182	2186	HO-1	T103	UMLS:C0538674
28464602	2189	2194	Nrf-2	T103	UMLS:C0289507
28464602	2214	2226	intervention	T058	UMLS:C0184661